Table 1.
Conventional Psoriasis (CP) | Scalp psoriasis (SP) | Palmoplantar psoriasis (HF) | Controls (C) | P-value | |
---|---|---|---|---|---|
Age (Mean, Range) | 51.5 (35–74) | 59 (32–72) | 49 (33–65) | 42 (20–73) | CP vs SP: p = 0.528 |
CP vs C: p = 0.311 | |||||
SP vs C: p = 0.122 | |||||
Gender (F:M) | 1:7 | 4:4 | 2:0 | 7:2 | CP vs SP: p = 0.282 |
CP vs C: p = 0.015* | |||||
SP vs. C: p = 0.335 | |||||
Age of onset (Mean, Range) | 30.5 (1–62) | 38.5 (3–58) | 38.5 (28–49) | N/A | CP vs SP: p = 0.563 |
Duration of disease (Mean, Range) | 25.2 (8–60) | 18.1 (3–56) | 10.5 (5–16) | N/A | CP vs SP: p = 0.316 |
BMI (Mean, Range) | 26.7 (24.3–37.2) | 25.7 (18.6–27.6) | 31.3 (22.7–39.9) | N/A | CP vs SP: P = 0.195 |
Unadjusted p-values are derived from pair-wise comparisons of psoriasis subtypes by the Mann-Whitney U test for continuous variables and Fisher’s exact test for categorical variables. The palmoplantar psoriasis group was not included in the statistical analyses due to small sample size. *p ≤ 0.05.